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ABSTRACT 
Title of the abstract : Genetic profile among children with congenital nonsyndromic hearing 
impairment, a study from a tertiary care centre in India 
Objective: To detect the percentage of GJB2 gene mutation in congenital non-syndromic 
hearing impaired children presenting at a tertiary care centre 
Methods: This is a pilot study conducted, 96 children were included in the study – 86 being 
retrospective.  
Children presenting with history of nonsyndromicsensorineural  hearing impairment in the 
department of ENT of our hospital were enrolled in the study. . History was obtained based 
on information obtained by a combination of self-reporting and physician assessment. 
Clinical evaluation including physical examination, hearing evaluation, blood investigations 
including genetic test were done. Genetic test were done in Department of Clinical Genetics 
at CMC. 
Results: In this study there were 96 probands, 36 males and 60 females. Among the probands 
46 i.e. 47.9% had profound hearing loss. In our study we found Connexin 26 mutation in 
13.5% of children with nonsyndromicsensorineural hearing loss. Out of the 36 boys, 19.4% 
had gjb2 mutation and 10% of the girls had that mutation however. In simple words, there is 
no evidence of association. We also found in our study all probands with GJB2 mutation had 
profound hearing loss. In our study we found 47% of GJB2 positive probands tested positive 
for W24X. 6.3% of the total probands tested positive for W24X mutation. Out of the total 
probands tested,5.6% of males and 6.7% of females tested positive for W24X. We also found 
that all probands with W24X had profound hearing loss.In our study among the probands 
tested 38.5 % were born to consanguinous marriage. There are 37 of the children from  
consanguineous marriage of which 29.7% had GJB2 mutation and 3.4% out of non-
consanguineous had mutation and this difference was highly significant Among probands 
born to consanguineous marriage, 62.2% had profound hearing loss as compared to 39% born 
to nonconsanguinous marriage 
This study has shown that Connexin 26 mutation is less common in India than in western 
population.In our study nearly half of probands with GJB2 mutation were W24X positive and 
this is the commonest mutation in Indians. Nearly one third of consanguineous marriage with 
non-syndromicsensorineural hearing loss were GJB2 positive. In this study we also found 
that all children who were GJB2 positive had profound hearing loss. To conclude, genetic test 
have many benefits and most impotantly if found positive it helps in early intervention. 
Key Words : Hearing Impairment, GJB2 Mutation, W24X gene, RFLP 
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INTRODUCTION 
Hearing impairment is among the common birth defects seen all over world and 
sensorineural hearing impairment isthe most prevalent disorder among the newborn. It 
was found that bilateral sensorineural hearing loss of ≥ 40dBHLwas seen in one of every 
500 newborns. The increase in prevalenceis uptoto 2.7 per 1000 before the age of five 
years and to 3.5 per 1000 at adolescence [1].Studies have shown that the cause for 
hearing impairment in in at least two-thirds of children withprelingual hearing 
impairment is inherited.In the remaining one-third of children hearing impairment  is due 
toeither  environmental factors or genetic factors which were not identified. 
Congenital cytomegalovirus (CMV) infection isthe most common environmental cause 
(non-genetic)of hearing impairment found in most of the studies done world over. 
Bacterial infection, birth hypoxia or anoxia, hyperbilirubinemia, and the use of ototoxic 
medications are the other common environmental causes seen in the newborns. 
The inner ear to function correctly needs a tight control of ion movements across its cell 
membranes .The inner ear has an elaborate system by which it maintains the critical K+ 
and Na+ concentrations found in the endolymph and perilymph. The endocochlear 
potential is anequilibrium potential due to K+ ion concentration. The potential is 
produced by the striavascularis. 
Gap junctions are the mainchannels for intercellular communication. These channels are 
important for passage of ions and metabolites across adjacent cells. Hundreds tothousands 
of gap-junction channel units are required to form protein structures that get inserted into 
plasma membrane and form gap junctions.  Gap junction channels span two neighbouring 
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cells. Striavascularis needs the K+ ions to move via gap junctions before they are secreted 
back into the endolymph..(2) Connexins (Cxs) are proteins, they are the building blocks 
forming thegap-junction channel (GJCh).  Connexins form themain routes for 
intercellular communication. Many diverse hereditary disorders of humans, like cataracts, 
oculodentodigital dysplasia,  and nonsyndromic or syndromichearing impairment are 
known to be caused due to mutations involving connexion gene.(3)Among the gap 
junctions seen in supporting cells of cochlea the most commonly expressed isoforms are 
Cx26 and Cx30. 
GJB2 isthe gene encoding for connexin26 (Cx26). It was the first gene found to be 
associated with an autosomal recessive form ofdeafness(4).Inherited hearing loss is 
monogenic in most of the cases. Among the neonates who are not able to pass the 
newbornscreening for hearing impairment and are found to have genetic hearing loss, 
80% of them will have no other positive physical findings. In these neonates the hearing 
impairment is classified as nonsyndromic. In the rest 20% of neonates, the hearing 
impairment is associated with other physical findings. These neonates are said to be 
syndromic [5]. There are more than 400 syndromes recognised which are associated with 
hearing impairment.  Among these syndromes Usher syndrome, Jaervell and Lange-
Nielsensyndrome and Pendredsyndrome are the most frequent [6]. 
There are different ways of inheriting monogenic hearing impairment.Autosomal 
recessive nonsyndromic hearing loss (ARNSHL) is the cause in about 80% of children 
with genetic hearing impairment. Most of these children haveprelingual, hearing 
impairment. Autosomal dominant nonsyndromic hearing loss (ADNSHL) accounts for 
hearing impairment in the rest 20% of children. In these childrenhearing impairment is 
most often postlingual. In less than 1% of children, the hearing impairment is due to 
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inheritance through the X-chromosome or the mitochondria [7]  Genetic test are useful as 
they allow parents to understand the cause of their child‘s deafness and help on deciding 
further course of action.   
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AIMS AND OBJECTIVES 
To detect the percentage of GJB2 gene mutation in congenital non-syndromic hearing 
impaired children presenting at a tertiary care centre 
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REVIEW OF LITERATURE 
Hearing impairment is among the common birth defects seen all over world and 
sensorineural hearing impairment isthe most prevalent disorder among the newborn. [1]. 
Hearing impairment is classified in several ways. Conductive hearing loss mainly refers 
topathology of the outer or middle ear whereas sensorineural hearing loss implies an inner 
ear defect. Mixed hearing loss is when both conductive and sensorineural hearing 
impairment occur together. Depending on the age of onset, hearing loss is also classified 
as prelingual (before development of speech ), also referred to as congenital (all 
prelingualhearing impaired children cannot be classified as  congenital ) or postlingual 
(after development of speech).  
Hearing impairment is clinically and genetically heterogeneous. When impaired auditory 
function is the only clinical finding it is called non-syndromicforms of deafness.When 
hearing impairment is associated with other symptoms or anomalies, it is called 
syndromic forms of deafness.Mutational changes involvingConnexin 26 is the most 
common molecular defectseen in nonsyndromicautosomal recessive deafness. Connexin 
26 is a gap junction protein seen in cochlea. It is encoded by GJB2 gene.Hearing 
impairment can be caused by defect in any two of the four alleles from GJB2 and GJB6. 
There can be either monogenic or digenic inheritance with these genes. There are 
different ways of inheriting monogenic hearing impairment.Autosomal recessive 
nonsyndromic hearing loss (ARNSHL) is the cause in about 80% of children with genetic 
hearing impairment. Most of these children have prelingual, hearing impairment. 
Autosomal dominant nonsyndromic hearing loss (ADNSHL) accounts for hearing 
impairment in the rest 20% of children. In these childrenhearing impairment is most often 
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postlingual. In less than 1% of children, the hearing impairment is due to inheritance 
through the X-chromosome or the mitochondria [7] 
Since the beginning of the 19
th
 Centuryit was known that heredity plays an important role 
in hearing impairment. In 1857, William Wilde, an Irish otologistconducted a studyfrom 
data collected in census records by asking questions about deaf individuals. He found that 
deafness in one or both the parents and consanguinity among parents were important 
indicators for hereditary aetiology in some of the hearing impaired individuals.(8) 
In 1883, a report was published by Alexander Graham Bell ―Memoir upon the Formation 
of a Deaf Variety of the Human Race‖. This memoir had a retrospective study of records 
taken from schools for the hearing impaired in the United States.(9) Bell did a study on 
the frequency of relatives of deaf students who had hearing impairment.. He also analysed 
the hearing levels of the children born of marriages among those who were congenitally 
deaf and compared his data with individuals who were adventitiously deaf. After the 
study, Bell had presented his concern about ‗‗the formation of a deaf variety of the human 
race in America,‘‘. Bell found that there was arise in the frequency of congenital deafness 
in the population. Bell argued that the increase in numbers of residential schools for 
education,the use of sign language, and the formation of societies and conventions for 
deaf people led to decreased mating choices and fostered intermarriage. This led to 
increase in frequency of deaf individuals in the population. Geneticists all over world did 
not approve of Bell‘s concerns. They argued that due to extreme heterogeneity of genes 
causing hearing impairment, this was highly unlikely. However, recent evidence have 
shown that, assorted mating among the hearing impaired population in combination with 
relaxed selection have led to preferential amplification of the commonest forms of 
recessive hearing impairment.(10) 
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ANATOMY 
The cochlea is a bony structure which is spiral in shape like a snail and it forms the 
sensory organ of hearing. The cochlea in humans has a little more than two and a half 
turns. If it is uncoiled and made straight the cochlea has a length of 3.1–3.3 cm. The 
cochlea has a height of approximately 0.5 cm in humans . The cochlea (together with the 
vestibular organ) is totally enclosed in the temporal bone, which is one of the hardest 
bones in the entire body. The cochlea and the vestibular organs are together referred to as 
the labyrinth. Bony labyrinth is formed by the bony structures of inner ear and inside it 
contains membranous labyrinth. The cochlea is made of three canals filled with fluid: the 
scala vestibule, the scalamedia and the scalatympani . The scala media is located in the 
middle of the cochlea. Reissner‘s membrane separates scala media from the 
scalavestibuli. The basilar membrane separates scala media from the scala tympani. There 
is similarity in the ionic composition of the fluid of scala media and intracellular fluid. 
Scala media is rich in potassium and low in sodium. The ionic composition of fluid in 
scalavestibuli and scala tympani is similar to extracellular fluid such as the cerebrospinal 
fluid, it is rich in sodium and poor in potassium.  
The scala media becomes narrow towards the apex of the cochlea, it ends just short of the 
apical termination of the bony labyrinth. There is an opening near the apical termination 
of the bony labyrinth which is called helicotrema, it allows communication between the 
scalavestibuli and scala tympani. In humans, the area of this aperture of helicotrema is 
approximately 0.05 mm2. The basilar membrane separates the sounds according to their 
frequency (spectrum). The organ of Corti is situated along the basilar membrane, it is 
made of sensory cells (hair cells). These cells transform the vibration of the basilar 
membrane into a neural code. 
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Organ of Corti 
The organ of Corti is made of many different kinds of cells. The sensory cells are the hair 
cells and they are so named because of the hair like bundles that are located on their top. 
The hair cells are arranged in rows along the basilar membrane. The hair cells have 
bundles of stereocilia on their top . Two main types of hair cells are seen in the organ of 
Corti, the outer hair cells and the inner hair cells.  
The human cochlea has approximately 12,000 outer hair cells which are arranged in 3–5 
rows along the basilar membrane, and approximately 3,500 inner hair cells that are 
arranged in a single row. On each outer hair cell, they have 50–150 stereocilia. The 
stereocilia are arranged in 3–4 rows that assume a W or V shape whereas the inner hair 
cells stereocilia are arranged in flattened U-shaped formation. Tunnel of Corti lies 
between the row of inner hair cells and the rows of outer hair cells. . Tunnel of Corti is 
bordered by inner and outer pillar cells . The outer hair cells are different from the inner 
hair cells in several ways. The outer hair cells appear cylindrical in shape while the inner 
hair cells appear flask shaped or pear shaped . The stereocilia are linked to each other 
with specific structures called crosslinks. The tallest tips of the outer hair cell stereocilia 
lie embedded in the tectorial membrane seen overlying the stereocilia,.  
The tips of the inner hair cell stereocilia are not embedded in the tectorial membrane. The 
outer hair cells in the apical region of the cochlea are longer than in the more basal 
regions. The outer hair cells are approximately 8 µm long in the apical region and less 
than 2 µm in the base. The diameter of the longest outer hair cell is thus approximately 
one tenth of the diameter of a human hair. Inner hair cells have similar dimension in the 
entire cochlea and all have approximately the same number of stereocilia (approximately 
9 
 
60). The stereocilia on inner hair cells that are situated at the base of the cochlea are 
shorter than stereocilia of hair cells that are located in the apical region of the cochlea. In 
addition to hair cells, there are other types of cells found in the cochlea. Supporting cells 
seen in organ of Corti are the Deiter‘s cells and Henson‘s cells, inner phalangeal and 
inner border cells. The striavascularis is located between the perilymphatic and the 
endolymphatic space along the cochlear wall. The striavascularis has a rich blood supply 
and its cells are rich in mitochondria, indicating that it is involved in metabolic activity. 
Many of striavascularis intermediate cells have a high content of melanin. The spiral 
ligament, to which the basilar membrane is attached, supports the striavascularis. 
Basilar Membrane 
The basilar membrane is formed by connective tissue and it forms the floor of the scala 
media. It has a width of approximately 150 µm in the base of the cochlea and it becomes 
wider at the apex, it is approximately 450 µm wide at the apex.Basilar membrane changes 
in stiffness from base to apex, it is more stiff in the basal end than at the apex. Due to this 
gradual change in stiffness, sounds that reach the inner ear create a wave on the basilar 
membrane which travels from the base towards the apex of the cochlea. Basilar 
membrane in different regions responds differently to this wave, and the same region on 
basilar membrane will respond differently to waves of different frequency. This travelling 
wave motion forms the basis for the frequency separation that the basilar membrane 
provides before sounds activate the sensory cells that are seen along the basilar 
membrane. The frequency analysis in the cochlea is complex; it involves interactions 
between the basilar membrane, the surrounding fluid, and the sensory cells. The outer hair 
cells interact actively with the motion of the basilar membrane. 
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Innervations of Hair Cells 
There are three different types of nerve fibers that innervate the cochlea: afferent auditory 
nerve fibers, efferent auditory fibers (olivocochlear bundle) and autonomic (adrenergic) 
nerve fibers. The afferent auditory nerve fibers are bipolar cells, their cell bodies are 
located in the spiral ganglion. The spiral ganglion is located in a bony canal, called the 
Rosenthal‘s canal.  
The auditory nerve fibers innervating the cochlea pass through the habenulaperforata 
before they continue as radial fibers to the inner hair cells. In humans, the auditory nerve 
has approximately 30,000 afferent nerve fibers. There are two types of afferent fibersseen 
in cochlea. Type I afferent fibres are myelinated and have large cell bodies. Type I 
afferent fibres comprise about 95% of the auditory nerve fibers. Type II afferent fibres are 
unmyelinated and they have small cell bodies. Type II afferent nerve fibres comprise 5% 
of the auditory nerve. The auditory nerve fibers connect to the hair cells via synapses. 
These synaptic connections are different for inner and outer hair cells. Many type I 
auditory nerve fibers terminate on each inner hair cell while a single type II auditory 
nerve fiber connects to many outer hair cells. It has been estimated that each inner hair 
cell receives approximately 20 nerve fibers. The nerve fibers (type II) that make synaptic 
contact with the outer hair cells cross over the cochlear tunnel to reach the rows of outer 
hair cells, where each nerve fiber, called an outer spiral fiber, innervates many hair cells 
and extends apically as much as 0.6 mm along the outer hair cell region.  
The inner radial fibers (type I) are thus different from the spiral fibers (type II) as they 
terminate on single inner hair cell. The hair cells also receive different connections from 
the descending auditory nervous system, the olivocochlear bundle also known as 
11 
 
Rasmussen‘s bundle. Outer hair cells receive the largest number of such nerve fibers. The 
efferent fibers (approximately 500–600 in humans ) have their cell bodies in the nuclei of 
the superior olivary complex (SOC) of the brainstem. These fibers are of two kinds: One 
kind is the medial olivocochlearfibers that are large myelinatedfibers that originate in the 
medial superior olivary (MSO) complex and which terminate on outer hair cells. These 
fibers mostly originate from cells on the opposite side and thus cross the midline. Each 
outer hair cell receives many efferent fibers and each efferent fiber connects to many 
outer hair cells (11). 
ION HOMEOSTASIS IN THE EAR K+ Na+ 
The inner ear homeostasis refers to the processes by which the chemical equilibrium of 
inner fluids and tissues is maintained. The inner ear can function correctly only if there is 
tight control of ion movements across its cell membranes. The inner ear function includes 
hair cell function, regulation of extracellular endolymph and perilymph composition, and 
nerve impulse conduction. The major ions involved are  Na + and K+ but a significant 
role is also assigned to calcium (Ca), chloride (Cl) and others. The hair cells of the inner 
ear have advantage of operating within a unique ionic microenvironment of two distinct 
fluids. The apex of the hair cell and stereocilia are immersed in endolymph, whereas the 
cell body is bathed in perilymph. The reticular lamina separates the two fluid spaces, 
endolymph from perilymph. The hair cells maintain a negative intracellular potential of -
80mV relative to surrounding perilymph. The high K+ concentration of endolymph 
creates an endocochlear potential of +80mV relative to perilymph. This +80mV 
endocochlear potential couples with the -80mV hair cell intracellular potential for a 
differential potential of 160mV. This arrangement of endolymph and perilymph is 
important for hair cell depolarization when its stereocilia are deflected by travelling wave.  
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Stereocilia get displaced laterally either by shearing movement of the tectorial membrane 
or motion of the endolymphatic fluid. Stereocilia displacement allows K+ ions to enter 
the hair cell through apical transduction channels, which leads to hair cell depolarization 
and neurotransmitter release. The flow of K+ ions is down an electrochemical gradient 
that brings K+ into the cell from the endolymph and eventually out the base of the cell 
body into the perilymph. If the entire hair cell was surrounded by endolymph, the hair cell 
will not be able to function because the K+ ion concentration inside and outside the cell 
would be equal. Thus the higher K+ ion concentration seen around the stereocilia 
provides for a receptor current that does not require an energy dependent pump in the hair 
cell. When these two fluids are not different, transduction is compromised and hearing 
loss occurs (2). 
Na+ - K+ Transport Mechanism 
The sound stimulus cause vibration of ossicles of middle ear. Thesevibrationsare sensed 
by the transduction machinery contained in the cochlea in the inner ear. The cochlea is 
made of  threeparallel tubular compartments lying adjacent to each other: the 
scalavestibuli, the scala tympani, and the scalamedia. (3) The epithelial cells, fibrocytes, 
and hair cells form the principal cellular components of the cochlea. These cells are 
located in the wall of the cochlea. There arethree compartments forming the cochlea. 
They are filled with two types of fluids. The perilymph,fills the scala tympani and scala 
vestibule .The ionic composition of perilymph is similar to that of the extracellular fluid, 
it is rich in Na+ and poor in K+.  The endolymph,fills the scala media. The endolymph 
has a high concentration of K+ (150 mM ).The endolymph has a high positive potential. 
Studies have recorded endocochlear potential of approximately +80 mV. This 
endocochlear potential is important for the cochlea to function normally. The 
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endocochlear potential is due to equilibrium potential of potassium ions. This isproduced 
by secretion of potassium ions bystriavascularis. The striavascularis is a two-layered 
epithelium. It forms the lateral wall of the scala media (12). The potassium channelsfound 
in the plasma membrane of intermediate cells and K+ transporters seen in striavascularis 
in the basal membrane of marginal cells play a major role in K+ homeostasis. For the 
activation of hair cellsthe presence of endocochlear potential is essential. The sound 
produces which is transformed into electrical signals. These electrical signals are 
transmitted to the brain by the hair cells in the basilar membrane of the scala media. The 
hair cells are polarized cells. They have ciliated apical membrane which is exposed to the 
endolymph. Their cell bodies are in contact with  the perilymph (or cortilymph). Sound 
coming into ear causes vibration in the basilar membrane. This vibration induces 
deflection of hair cell cilia which lead to opening of mechanosensitivepotassium channels 
(13). Opening of these channels allow endolymphatic K+ to enter into hair cells. This 
leads to depolarization of hair cells. The large endocochlear potential increases the 
sensitivity of hair cells to vibration caused by sound.This forms a large driving force of 
+160 mV for K+ influx. It is the difference between the resting potential of hair cells (+80 
mV) lying in the perilymph and the endolymph potential (+80 mV). K+ is released into 
the perilymph after activation of the hair cells.The K+ than moves laterally via gap 
junctions. Potassium ions move from the perilymph back to the endolymph through the 
―cochlear lateral wall‖.This is also indicated by studies which showed that inhibition of 
flow of potassium ions from the perilymphatic space leads to inhibition ofendocochlear 
potential. Studies have also shown that endocochlear potential decreases after 
perilymphatic perfusion of potassium ion free solution.  Different cellular components 
found in the cochlear wall form this recirculation pathway. K+ is transported along the 
supporting and epithelial cells in the basilar membrane. Potassium ions are transported to 
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fibrocytes in the spiral ligament which forms lateral wall connective tissue. K+ ions are 
eventually transported to epithelial cells of the striavascularis, from where they are 
pumped into the endolymph. The K+ circulation is in cochlea is by formation of two 
autonomous syncytia in the lateral wall of cochlea. One is formed by an epithelial gap-
junction network (epithelial cellsand supporting cellsseen on the basilar membrane), and 
the other is formed by connective tissue gap-junction network (epithelial cells of 
striavascularisand fibrocytes of spiral ligament). These two groups of networks promote 
the K+ circulation from perilymph to endolymph.The endocochlear potential is created by 
the striavascularis. The endocochlear potential is reduced significantly following loss of 
Cx30 in the mouse ear (45) without changes in the potassiumion concentration and 
amount of endolymphin scala media.There are mutations in Cx26 which do not affect 
ionic conductance, like V84L, but they selectively affect IP3 permeability. These 
mutations have been associatedwith hearing impairment.Thefunctionof  gap-junction 
channels in the potassium circulation, and generation of the endocochlear potential is 
complex and related to transport of other metabolites also. 
The inner ear has an elaborate system by which it maintains the critical K+ and Na+ 
concentrations in the endolymph and perilymph. Following release by the hair cells K+  
moves laterally through gap junctions between supporting cells in the organ of Corti. 
When ions reach the spiral ligament, the gap junctions between fibrocytes move ions up 
to the striavascularis for secretion back into the endolymph. The striavascularis has a well 
developed ion transport system of diverse channels and transporters that move K+ into 
the endolymph and Na+ out of the endolymph and into the perilymph. Other ions, such as 
Cl, H+ and Ca2+ also are actively transported into or out of the endolymph by the 
striavascularis. 
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The major ion channels and transporters which are involved in stria ion movement 
include Na K adenosine triphosphatase, the Na K 2Cl cotransporter, epithelial Na 
channel, several different K channels, Cl channels and the K H exchanger.The position of 
these ion channels and transporters in the striavascularis are determined by the direction 
of movement of a particular ion. Many of these ion channels and transporters also occur 
in secretory or absorptive tissues, but their relationship to the luminal or basal sides of 
epithelial cells varies. It depends on the required direction of K+ and Na+ flow. The +80 
to +90mV endocochlear potential is generated by the intermediate cells within the 
interstrial space. The marginal cells, even though serving as the final transport epithelium 
to move K+ into the endolymph, they do not appreciably alter the endocochlear potential.  
The cellular mechanism for moving K+ to the strial intermediate cells can be thought of 
as an epithelial complex made up of the fibrocytes in the spiral ligament, the basal and 
intermediate cells of the stria and the capillary endothelial cells. All of these cells are 
interconnected by gap junctions, facilitating the transport of K+ between them and into 
the intrastrial space. The tight junctions of the vascular endothelial cells and basal cells 
also contribute to the endocochlear potential by limiting intercellular leakage of ions. The 
exchange of ions through these cells is driven by the Na K ATPase system in the 
fibrocytes, intermediate cells and marginal cells. Thus any cochlear disorder that 
compromises these strial cells layers, channels, transporters or tight junctions will reduce 
the endocochlear potential and cause hearing loss. Also, the ion transport components of 
the stria system are controlled by multiple genes, making the production of endolymph 
susceptible to a variety of genetic disorders(2). 
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COCHLEAR HOMEOSTASIS 
The mammalian cochlea  has a complex anatomy. It is made of sensory hair cells and 
different types of supporting cells. The supporting cells seen in cochlea include 
Hensencells, pillar cells, Deiters cells, and Claudius cells. Gap junction channels couple 
these supporting cells bothelectrically and metabolically by forming channels for 
transport of ions and metabolites..Gap junctions in cochlea when compared to other cells 
in the body, are not found between the sensory cells i.e. inner and outer hair cells. No gap 
junctions are seen between sensory and non-sensory cells in mammals . 
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Other than the gap junctions seen between supporting cells, additional gap junctional 
coupling is seen in the striavascularis, the spiral limbus, and other cochlear structures 
.Two distinct types of gap networks are seenin the cochlea. There are epithelial cell gap 
junction network between the non-sensory epithelial cells. There is also a connective 
tissue gap junction network seen among the connective tissue cells of the lateral wall of 
cochlea. These gap junction networks are important for cochlear ionic homeostasis. 
The anatomy of cochlea is organized in a such a manner that it forms separate 
compartments containing perilymph and endolymph. Cochlea separates the ionic 
environment in its compartments presented to the sensory cells within this organ. The 
cochlea consists of three compartments, which are filed with the perilymph and the 
endolymph . The perilymphatic space is similar to other extracellular fluids, it contains a 
high Na+ and low K+ solution. In contrast, the apices of the cochlear epithelial cells face 
the endolymph, which has an opposite cationic composition similar to intracellular fluid 
of high K+ and low Na+ ions. The endolymph has a positive endocochlear potential of 
+80 to +100 mV and the perilymph has a negative potential of about -80 mV. 
Acoustically evoked receptor potentials in response to sound are generated by movement 
of K+ ions via mechanosensitivecation channels on stereocilia, into the sensory hair 
cellsfrom the endolymph. These potassium ions are then released into the basolateral 
extracellular spaces of the perilymph by the cochlear epithelial cells. These K+ ions are 
then taken up by supporting cells of cochlea and secreted back into the endolymph. The 
gap junction networks formed by supporting cells are important forrecirculation of 
cochlear K+ ions. They provide an intercellular route of transport of ions and 
metabolites.(15) 
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Connexins (Cxs) are proteins, they are the building blocks forming the gap-junction 
channel (GJCh). Connexins form important channels for intercellular communication.Gap 
junctions are important for ionic and metabolic coupling of adjacent cells. Hundreds to 
thousands of gap-junction channel units are required to form protein structures that get 
inserted into plasma membrane and form gap junctions. Gap junction channels span two 
neighboring cell.(3)andhelp in transport of different small molecules, including ions, 
nucleotides, siRNAs, and inositol phosphates . Under transmission electron micrographs 
each gap junction is recognized as a uniform narrow gap of about 2 nm between segments 
of plasma membranes of two adjacent cells .Each gap junction is made of channel 
particles which are closely aggregated in the membraneas seen in freeze-fracture electron 
micrographs. These intramembranous channel particles are made of assemblies of 
sixconnexin proteins. There are different connexin (Cx) subunits like Cx26, Cx30, Cx31 
and Cx43  seen in the mammalian inner ear.(15) 
Docking of two independent hemichannels, also called as connexions  present in the 
plasma membranes of the two adjacent cells lying apposedto each other will form a gap-
junction channel. Six connexin subunits oligomerize in Endoplasmic reticulum and Golgi 
bodies to constitute a hemichannel. This hemichannelis than transported to the plasma 
membrane by the secretory pathway. This movement is caused by microtubules attached 
to the vesicles (16). At sites of cell apposition on plasma membrane, there is docking of 
twohemichannel to form a gap-junction channel. This gap junctional channel allows 
formation of an aqueous pore. The aqueous pore connects cytoplasms of two adjacent 
cells. Theseaqueous pore allow transport of ions and small molecules.  
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These channels transportmolecules with a size of about 1 kDa includingsecond 
messengers (cAMP, cGMP, ATP, etc.) and diverse metabolites (sugars, amino acids, 
glutathione, etc.).(3) 
It has been found that hemichannels which lie in plasma membrane undocked with other 
hemichannels can open and allow transport of ions and metabolites . These hemichannels 
are seen to work in both physiological and pathological conditions.(16).There is a family 
of homologous geneswhich encodes for all the different connexins. Human genomic 
database was screened and20 connexin genes were identified (17). All connexinshave the 
same basic structure in the plasma membrane. The connexions have their one intracellular 
loop, amino and carboxyl terminifacing the cytoplasm. Connexins are made of four 
transmembrane domains with two extracellular loops.  
The similarityamong different connexin molecules is high but there are different proteins 
found in the intracellular loop and the carboxyl terminus. The difference between the 
proteins is significant and it is here where many molecules likecytoskeletal binding 
proteins and kinases act to regulate its activity.Heteromeric channels and heterotypic 
channels add to the variations in different gap junctions.Heteromeric channels are made 
of more than one type of connexin molecule. Heterotypic channels are constituted by the 
docking of two hemichannels where each is made by a different connexin molecule. 
These diverse connexinmolecules will form channels with variable functional and 
regulatory properties. The importance of gap-junction channelwas understood when many 
genetic diseases were found to be associated with mutations in variousconnexin genes 
coding for gap junctions found in different cells of the body.  
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Many diverse hereditary disorders of humans, like cataracts, oculodentodigital dysplasia, 
and nonsyndromic or syndromichearing impairment.are known to be caused due to 
mutations involving connexion gene.Many of the syndromic hearing impairment are 
found in association with various skin disorders (3). Among the different diseases caused 
by mutation of connexin in humans, hearing impairment is the most common.  Even 
though inherited hearing impairment is genetically heterogeneous, a large number of 
patients in every population tested around the world, has been seen to be related with 
mutations in the gene encoding Cx26 (GJB2). Mutations in four other connexins, Cx30, 
Cx31, Cx32, and Cx43, are also associated withnonsyndromic or syndromicsensorineural 
hearing impairment (5, 6). Hearing impairment in mutations associated with Cx43 is 
controversial, as they were found to be located in the Cx43 pseudo gene on fifth 
chromosome. But in recent studies in Taiwanese hearing impaired patients,a new 
mutation was found in functional Cx43 gene.(3) 
Among the gap junctions seen in cochlear supporting cells the most commonly expressed 
isoforms are Cx26 and Cx30. Both  Cx26and Cx30 are seen in both the epithelial cell and 
the connective tissue cell gap junction system, of the cochlea. There are other types of  
connexions molecules  present in the cochlea . 
Different connexin molecules contribute different types of connexin proteins to the gap 
junction( heteromeric and heterotypic gap-junctional channels ). This in turn increases the 
functional diversity of gating and permeability. Gating of different gap junction channels 
depends on differentfactors like (a) transjunctionalvoltage (b) membrane potential , (c) 
pH,(d)calcium, or (e) membrane tension . Different connexin channels have different 
sensitivity to voltage-gating. Hybrid channel configurations of gap junction add to the 
diversity of these channels. A homotypic channel has an even structure which will have 
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symmetric voltage-gating properties on both sides. A heterotypic channel with each 
hemichannel having its own exclusive gating can have disproportionately rectified 
voltage-gating properties. Asymmetrically rectified voltage gating is seen in both Cx26 
and Cx30 channels when both form heterotypic channels in vitro. Further structural 
diversity is seen when Cx26 and Cx30 coassemble to form heteromerichemichannels in 
the liposomes. The existingmatch of different expressed connexin subunits can 
profoundly change the type of substances that can be transported across the gap junction. 
Both syndromic and nonsyndromic forms of hearing impairmentcan be caused by 
mutations in human Cx26, Cx30, or Cx31 (GJB2, GJB6, and GJB3). Hearing impairment 
by mutation of Cx26 or Cx30 has also been produced by genetically engineered in mice. 
These observations have proved that normal functioning of the inner ear is dependent on 
normal functioning of gap junctions. But these observation do not explain why other 
connexin isoforms are not able to compensate in case of genetic mutation leading to loss 
of a single gap junction subunit within the cochlea. Further studies have shown that 
mutations in a single gap junction will lead to changes in permeability, gating properties 
and change the type of molecules being transportedbetween the plasma membrane of 
coupled cells.  
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CONNEXINS 
Connexins are tetraspantransmembrane proteins extending across cell membranes in 
contact with each other. Connexions arehexameric assemblies of connexin seen in the 
plasma membrane. These connexions dock with other connexions in plasma membrane of 
neighbouring cells clustering into a plaque and forming gap junction channels.There is a 
small extracellular gap of 2–3 nm between the two adjacent plasma membranes with 
connexions forming the plaque [18]. GJB2 is the gene coding for connexin26 (Cx26).  
It was the first gene found to be associated to an autosomal recessive form of hearing 
impairment, DFNB1.(4)  It was also associated with a dominant type of rare hearing 
impairment , DFNA3 [19]. In the studies done on connexin mutations, 90 recessive 
mutations have been discovered forGJB2, further studies are still going on. These 
mutations can be diverse and include (a) nonsense, (b) missense, (c) splicing, (d) frame–
shift mutations and (e)inframe deletions [21]. These GJB2 mutations are responsible for 
about 50% of sensorineuralnonsyndromic hearing loss in many populations as seen in 
studies done around the world. There is a carrier frequency of 1 in 33 for GJB2 mutation 
among the Mediterranean population [20].  
Two large deletions take placein initial part of GJB2 in GJB6 are associated with 
DFNB1–linked inherited cases with absentmutation in GJB2. On humanchromosome 13 
is the gene coding for connexin30 (Cx30) lying 30 kb telomeric to GJB2 [21]. Only one 
mutation has been reported for connexin 30 where at position 5 there is a threonine–to–
methionine substitution [22]. Detailed structure of wild connexin 26 is described by the 
recent 3.5–A˚ crystal structure [23]. Cx26 and Cx30 have 77% of similarity in their amino 
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acid. Both the connexions are commonly expressed in nonsensory cells of the inner ear 
[24,25] They form two discrete intercellular gap junction networks [26].  
The epithelial gap junction network in the murine cochlea, starts development in embryo 
around sixteenth day.The organ of Corti is formed by supporting cells located in the 
sensory epithelium . These cells are connected by gap junction network.In comparison the 
connective tissue gap junction network starts development around birth [27] [28]. Mouse 
models confirmed the importance of Cx26 and Cx30 for normal auditory role [29].  
Mouse models have helped to understand the connection between connexin expression, 
inherited deafness, endolymphatic K+ concentration and endocochlear potential 
[30,31,32]. Mouse models also helped to understand movement of nutrients among the 
cells of sensory epithelium of the inner ear [33]. They also helped in understanding 
cellular degeneration associated with connexin mutation occurring in cochlea.[34] 
Organization of Gap Junction in the Mammalian Cochlea  
Kikuchi et al. In 1995 described the gap junction networks in cochlea. They found that 
there exist two differentgap junction networks, the epithelial cell system and the 
connective tissue cell system. They found that both Cx26 and Cx30 appear very 
frequently  throughout these systems . The epithelial cell gap junction system 
includesdifferent types of cells like interdental cells found in the spiral limbus, cochlear 
supporting cells, and root cells seen in lower part of the spiral ligament. Gap junctions are 
absent between the sensory hair cells and the surrounding supporting cells. The 
connective tissue cell gap junction system is made of different types of cells.  It includes 
(a) fibrocytespresent in the spiral ligament and suprastrial zone, (b) basal and 
intermediate cells seen in the striavascularis, mesenchymal cells seen lining the 
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perilymphatic space of the scalavestibuli, (c) the supralimbalmesenchymal dark cells and 
(d) the fibrocytes in the spiral limbus. The cells forming the epithelial cell gap junction 
system are lined by a basement membrane. The epithelial cell gap junction have no direct 
contact with the underlying connective tissue cells. 
Recycling Mechanism for Potassium ions via Gap Junctions in the Cochlea  
Endocochlear potential formed by the different ionic composition of endolymph and 
perilymph is important for the normal auditory function of cochlea.Acoustic stimuli of 
cochlear sensory cells leads toentry of potassium ions into the hair cellsfrom the 
endolymph. Thepotassium ions are then transported basolaterallyout of the hair cells to 
the extracellular spaces. Cochlear supporting cells move potassium ions to the lower part 
of the spiral ligament laterally via the epithelial cell gap junction system. The potassium 
ions move further laterally to extracellular space within the spiral ligament. The spiral 
ligament is the outermost element of the epithelial cell gap junction system. Potassium 
ions are taken up by the Na, K-ATPase and Na-K-Clcotransporter (NKCC1) present in 
the type II fibrocytesplasma membrane. Potassium ions move into the connective tissue 
gap junction system after the uptake by type II fibrocytes. At the basal cell layer of the 
striavascularispotassium ions pass through the tight junctional barrier. Potassium ions are 
then transported to the striavascularis. The marginal cells seen in the 
striavascularissecrete the potassium ions into the endolymphatic space, to be reused 
formechanosensory transduction, after taking up the ions from extracellular space by Na, 
K-ATPase and Na-K-Clcotransporter (NKCC1). There is an anothermechanism for 
potassium cycling. It involvescalcium waves induced by inositol triphosphate. 
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Voltage Gating of Cx26 and Cx30 in Cochlear Cell Pairs  
Irregular current flow between cells in the cochlea are produced due to asymmetry in 
transjunctional voltage gating due to diverse coupling of different connexions and also 
due to dependence of coupling on membrane potential. 
Voltage gating properties of Cx26 and Cx30 in vitro have been documented in various 
studies. Both Cx26 and Cx30 are mainly invoved in forming gap junctions between 
cochlear supporting cells. Many studies have shown that heterotypic or heteromeric gap 
junction channels are seen amongsupporting cells. These gap junctions will have variable 
stoichiometry and posttranslational modifications leading toirregular voltage gating seen 
in cochlear supporting cells. Thisinduces a directional transjunctional current amid 
coupled supporting cells .After acoustic stimulation this directional currents can lead to a 
directed funnelling of ions like potassium ions away from the sensory cells. Studies have 
shown that variable permeability is seen inheteromeric Cx26 and Cx30 channels when 
compared with homomeric gap junctions. This increasesthe functional diversity of gap 
junction channels in the cochlea. It was also found that Cx26 and Cx30 heteromeric 
channels had faster Ca2+ intercellular signalling which may prove to have critical 
functional consequences..(3)  
In addition to the gap junction channels which promote intercellular communication, 
hemichannels are also seen on plasma membrane in both physiologic and pathologic 
conditions. (35) These hemichannels lead to increased plasma-membrane permeability. 
The mature organ of Cortihas functional hemichannelswhich under certain 
conditionspermit uptake of anionic molecules with a large size, as well as the release of 
ATP. Studies have shown that mutation of connexin leading to hearing impairment can be 
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due to hybrid Cx26 with Cx30 channels. Mutation of either connexion of a hybrid 
Cx26/Cx30 channel can change the channel function even when the other docking 
connexion is normal. This mutation can disrupt cochlear homeostasis and hinder K+ 
recycling. Presence of  hybrid channels can explain why homotypic Cx26 or Cx30 cannot 
compensate for the mutations in the other gene. 
Inner Ear Gap Junction Permeability  
All connexins have 1 to 1.5 nm diameter of the gap junction channel lumen.Itcorresponds 
with the diameter of molecules that can pass through the gap junctions. Despite the 
common size of pore diameter, different connexin isoforms forms different channels that 
behave differently. Gap junction channels have preferences for charge  and discrimination 
for metabolites with diameters below the upper limit of the pore size. It has been shown 
in studies that in transfected cells, both cationic and anionic dyes can pass through Cx26 
whereas Cx30 channels can pass cationic dyes but do not allow passage of Lucifer yellow 
and Alexa Fluor 488 which are anionic dyes. A similar charge selectivity is also seen in 
gap junctional coupling in cochlear sensory epithelium. It has been found in experiment 
done on permeability thatCx26 preferably allows passage of anions as it allows passage 
of negatively charged dyes. Important molecules for cell signalling likeATP, cAMP, 
cGMP, glutamines and IP3 are all anions. So it is believed that Cx26 channels are 
important in intercellular signalling and passage of nutrients across plasma membrane in 
cochlea.Mutations causing deafness on functional analysis showed similar findings. 
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Pharmacological Modulation of Gap Junction Coupling in Cochlear Supporting 
Cells  
Studies have shown that drugs causing ototoxicity influence supporting cell gap 
junctional coupling leading tocochlear pathology. Isolated Hensen cellshad decreased 
permeability of its gap junctions on exposure to gentamicin. It was also found that 
Cisplatin exposure led to uncoupling of fibroblast gap junctions.Further experiments 
showed that gentamicin ototoxicity was reversed by catalase and Hydrogen peroxide 
application promoted similar ototoxicity.These experiments proved that gentamicin 
initially stimulates production of Hydrogen peroxide which can inhibit gap junction 
coupling.Further studies are needed to find out the effect of free radicals and whether free 
radicals can influence permeability in gap junctions. 
Another pharmacological modulator studied is Nitric oxide (NO). Experiment showed 
that on applying sodium nitroprusside (SNP), which is a NO donor,on to Dieter cells led 
to inhibition of gap junction coupling. 
Experiment have been done on other modulators of gap junction coupling like membrane 
tension, temperature and pH but their mechanism of action is still doubtful.  
Loss of Function of Cochlear Connexin studied on Mouse Models 
Studies were done on mice after mutating or deleting Cx26 and Cx30 genes. These 
studies have shown importance of gap junctional coupling forcochlear homeostasis.In 
experiments done on mice, they were not able to survive after completely knocking out of 
Cx26. So targeted ablation of Cx26 was done in cochlea to study the effects. It was found 
that sound stimulation led to increased postnatal cell death in cochlea after normal 
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development of cochlea for fourteen days. This led to significant hearing 
impairment.These cell death were seen to occur near inner hair cells along with a 
decrease in endolymphatic potential. Endolymphatic potassium concenteration was found 
to be low. These experiments showed that loss of Cx 26 function led to reduced recycling 
of potassium in cochlea after potassium entered hair cells following sound stimulus.This 
potassium was secreted basolaterally by hair cells leading to increased potassium 
concenteration in extracellular perilymph. This blocked uptake of glutamateandled to cell 
death in cochlea. 
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These experiments proved the important role of epithelial gap junction network in 
cochlear function. These experiments could not elaborate all the functions of Cx26 as 
Cx30 was not able to compensate for the loss of function of Cx26. 
Another study was done using a different mouse model by transgenically expressing 
R75W in inner ear which is the dominant mutant negative for Cx26 to study the 
pathology of dominant mutations .R75W  mutation caused syndromic hearing impairment 
along  with skin manifestations.These mice developed profound hearing impairment. 
These mice also developed histological changes leading to degeneration of hair cells and 
tunnel of corti in mice cochlea. These experiments showed that  R75W affected 
potassium ion circulation in organ of corti and not extracellular perilymph, as was seen in 
other experiments. These experiments demonstrate that different pathologies can occur 
depending on type of connexin 26 mutation and the type of inheritance. 
Another animal study was done by knocking out Cx30.These mice had normal cochlear 
development but they were unable to maintain endocochlear potential. On exposure to 
sound stimulus apoptosis of cells in cochlear sensory epithelium was seen. This 
experiment again demonstrated that inspite of normal Cx26 function, no compensation for 
loss of Cx30 function was seen. These experiments suggest that gap junctions have other 
roles and they allow passage of other metabolites also. 
Functional Properties of Mutant Channels  
Most of the studies have shown that mutions of Cx 26 are the most common reason for 
both autosomal recessive and autosomaldominant hearing impairment. These mutations 
are also seen in sporadic congenital deafness . These mutations produce different effects 
leading to  nonsense mutations or insertion and deletion. These mutations cause 
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premature termination of protein translation. This leads tochange in a single amino acid 
by missense mutation. The most commonly found mutation involving Cx26 is 35delG. In 
this mutation there is termination of protein translation by deletion of one base resulting 
in a frame shift. This introduces a premature stop codon and results in cessation of protein 
translation.  
Studies have shown that since potassium is high intracellularly, the mutant channels may 
retain their permeability to potassium . It is believed that hearing impairment due to 
mutation is not fully due to problems in potassium recirculation but can be due to 
involvement of other molecules. It was found in certain studies that certain mutations led 
to decreased permeability of cell signalling molecule inositol 1,4,5-trisphosphate (IP3). 
Studies have shown that inositol 1,4,5-trisphosphate is important for calcium wave 
propagation for normal functioning of cochlea. This study showed that Cx26 mutations 
leading to hearing impairment where the gap junctions retain their ionic coupling is due to 
reduced permeability to other metabolites.(3). 
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Cx26 mutation leading to hearing impairment can be categorised into four types:  
a) mutations that can reducehemichanneltransport to the plasma membrane or gap 
junctional channel assembly;  
b) mutationswhere the channels do not function but the gap junctions are being 
formed 
c) mutations that createGJChwhich are functioning but  have atypical gating or 
permeability properties, like decreased IP3 permeability; and  
d) mutations that produce hemichannelslocated at the plasma membrane which will 
open under physiologic conditions, they may influencea ionic balance or the 
homeostasis of vital molecules that reduce cellular viability 
Etiology of Congenital and Early-Onset Hearing Impairment 
A lot of studies have been done to look at possible genetic and environmental causes of 
congenital and early onset hearing impairment.Tools of genetic epidemiology, including 
linkage analysis and molecular testing have helped to determine the causes of congenital 
hearing impairment. Studies have shown that prevalence and reasons of hearing 
impairment vary in different populations studied at different times.  It was found in 
studies that autosomal recessive, autosomal dominant, and X-linked genes were 
accountable for 76%, 23%, and 1% of the inherited cases (36). Studies done in United 
States by analysing  data collected from sample of deaf school children showed that 
hearing impairment in 36% of the children was sporadic (nongenetic), hearing 
impairment in 64% was caused dueto genetic causes (autosomal- recessive inheritance 
seen in 74%and autosomal-dominant inheritance seen in 26%) (37). By combining the 
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data from different sources it wasfound that in the United States, substantial hearing 
impairment is present in around 1.9 per 1000 infants at birth.(1) 
There are a large number of genes causing hearing impairment. Mutations at a single 
locus, DFNB1 led to hearing impairment in a large number (30%–40%) was not 
expected.DFNB1 includes GJB2 and GJB6 genes. These genes code for the Connexin 26 
(Cx26) and Connexin 30 (Cx30) subunits of gap-junction proteins.Inherited hearing 
impairment is commonly transmitted as a monogenic trait. Studies have shown digenic 
transmission also.(52) 
It was observedin many studies that individuals who were digenic compound 
heterozygotes had more severe hearing impairment when compared to GJB2 35 del G 
homozygotes. . Mutations at a single locus, DFNB1 leading to hearing impairment in a 
large number was believed to be due tointense assortative mating seen in hearing 
impaired populations and the relaxed genetic selection against hearing impairment due to 
introduction of sign language. Both these factors were significant, and were more 
pronounced after sign language was introduced 400 years ago.It was found using 
computer simulation, that these factors could have twice the frequency of DFNB1 
associated hearing impairmentover the past 200 years in the United States. 
Effect of Consanguinity in the Population  
Both assortative mating and consanguinity form important attributes for a population. 
They both can affect the incidence of hearing impairment in a population. In a population  
whenever a new recessive mutation first appears, due to stochastic processes there is a 
significant chance that it will be lost in further generations. Consanguinity in a population 
leads to phenotypic expression of some recessive mutations. These mutations may or may 
36 
 
not be naturally selected.Assortative mating comes into play once these mutations are 
expressed in the population in response to relaxed selection.Consanguinity, in a 
population, will influence all recessive mutations whether or not associated with hearing 
loss.AssortativematinG comparatively will influence recessive mutations associated with 
hearing impairment.In a given population recessive mutation associated hearing 
impairment will be increased byassortative mating .Genetic inheritanceenhanced by both 
consanguinity and assortative mating can increase the survival, expression, and spread of 
genes for hearing impairment. Sign language has improve the ‗‗genetic fitness‘‘ of the 
hearing impaired population, more so  whensign language is used by both hearing 
impaired and normal family members.This resulted in acceptance of deaf individuals into 
the community. This promoted assorted deaf to deaf marriages and further led to increase 
in hearing impairment in the population as there was usually only one type of genetic 
deafness prevalent in the population. It is well known that gene drift and consanguinity 
play important roles in the persistence and initial phenotypic expression of genes in these 
populations.It was also noted that relaxed selection and assortative mating further 
promoted the increases recorded in both gene and phenotype frequencies. This points to a 
founder effect in recessive mutation leading to hearing impairment. (38) 
LOCALIZATION AND ISOLATION OF GENE 
Loci fornonsyndromic hearing loss (NSHL) were discovered only after 1992 and mapped 
on the human genome. It is significant that research into genetic causes for hearing 
impairment lagged behind research into other sensory handicaps like blindness.Cloning of 
genes which were responsible for human hearing impairmentby  genetic tests has been 
delayed for a long time because the important proteins seen in normal hearing and hearing 
impairment have been identiﬁed only in the last ten years. Positional cloning of genes 
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associated with hearing impairment was also delayed than that of other disease genes. It 
was believed that mapping of genes responsible for hearing impairment was not possible 
by using linkage analysis. This was thought so because all the studies done by genetic 
community concenterated on prelingual hearing loss in Western countries. Prelingual 
hearing loss is congenital and severe  leading to deaf-mutism. This led to social isolation 
of hearing impaired and affected theirgenetic fitness.Most pedigrees seen in West 
contained only a restricted number of prelingual deaf individuals in aﬀected families as 
this has an autosomal recessive manner of inheritance. It was thought that due to large 
genetic heterogeneity of nonsyndromic hearing loss the linkage data seen in diﬀerent 
families cannot be shared as the number of genes involvedis large.Due to high 
heterogeneity in genes causing hearing impairment, localization of genes by conventional 
linkage analysis in such one-generation pedigrees was too trivial to localizeas the linkage 
power was too small. Because of this no recessive gene were mapped in Western 
pedigrees in initial studies. Another reason wasassortative mating introducedin a single 
family, diﬀerent mutant genesin the deaf community, this reduces the linkage analysis. 
Reservoir of consanguineous multiplex families were found in different ethnic 
communities in developing countries. In these families autosomal recessive hearing loss 
was seen in many family members due toconsanguinity.The benefit of studying these 
ethnic isolates was absence of assortative mating. The other benefit was that these 
families had limited living area and extended pedigrees were living together. This helped 
in accessibility to a large number of family members with hearing impairment. This has 
led to mapping of most autosomal recessive forms of hearing impairment in these 
families from developing countries. 
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LOCI FOR NONSYNDROMIC HEARING LOSS 
There is a standard classification for mutation loci. DFN (DeaFNess) represents deafness. 
It is followed chronological order of identiﬁcation of the locus indicated by a number. 
Autosomal dominant loci is denoted as DFNA, autosomal recessive loci is denoted as 
DFNB, X-linked loci is denoted as DFN.  
GENES FOR NONSYNDROMIC HEARING LOSS 
In the studies done so far 90 mutations involving Cx26 gene leading to nonsyndromic 
hearing impairment have been discovered. These mutations constitute nearly half of 
congenital cases of hearing impairments.(3) 
Inspite of the large heterogeneity seen in genetic hearing loss, 50% of non 
syndromicsenosrineural hearing impairment has been attributed to variants of GJB2 gene 
mutation inmost of the studies done so far. Studies in different populations have shown 
different alleles as being more common.Studies done on Ashkenazi Jewish population 
have shown the 167delT mutation to be more common in theirpopulation (39). Another 
study done on populations in Caucasians and in Mediterranean regions showed 35delG as 
more common.(40) In studies done on Japanese population, 235delC mutations are seen 
commonly.(41)In studies done in Ghana, R143W was found to be more common 
occurring GJB2 variant (42).Some studies have described the presence of W24X mutation 
in GJB2 gene (40),only in Indian population is this mutation seen in significant 
numbers(43).Studies done in the Kerala population on probands with hearing impairment 
using molecular screening showed that 36% were associated with mutations in the 
connexin26 gene. These values were similar to those reported in other 
studies.[44,18].W24X was the most frequent mutation seen in these probands with 
39 
 
hearing impairment.Out of 86 probands 28 were found to be homozygous for W24X 
mutation.The most common mutation reported from studies done abroad is 35delG, but 
this mutation was not detected in this study. In another study done recently in a North 
Indian population, 35delG mutations were found along with W24X mutation (45). These 
studies have shown that different mutations are seen in different populations. It also 
implies that certain mutations are specific for same population.(46) 
Restriction fragment length polymorphism 
RFLP, restriction fragment length polymorphism, is a technique that uses differences in 
homologous DNA sequences. It refers to homologous DNA molecules with difference 
among samples that are present at differentpositions of restriction enzyme sites. It also 
refers to a related laboratory technique by which these segments can be illustrated. In 
RFLP analysis,restriction fragments are separated according to their lengths by gel 
electrophoresis after the DNA sample is broken into fragments(digested) by restriction 
enzymes. 
Analysis technique 
The basic technique for detecting RFLPs involves a process known as a restriction digest. 
It is done by fragmenting a sample of DNA by a restriction enzyme, which can recognize 
and cut DNA wherever a specific short sequence occurs. Then agarose gel electrophoresis 
is used to separate the resulting DNA fragments. An RFLP occurs when among the 
individuals the length of a detected fragment differs. Each fragment length is accepted as 
an allele, and can be used in genetic analysis. 
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Applications 
In genome mapping and genetic disease analysis,study of RFLP variation is a vital tool. 
To find out the chromosomal location of a particular disease gene, the DNA of members 
of a family afflicted by the disease is examined. Then RFLP alleles showing a similar 
pattern of inheritance as that of the disease are searched. Once a disease gene was 
localized, other family members were checked by RFLP analysis to look for who was at 
risk for the disease, or who was likely to be a carrier of the mutant genes. 
GENETIC TESTING 
There are very few studies done on the effect of genetic counselling and genetic test for 
newborn hearing as a screening procedure. This is attributed to the difficulties associated 
in genetic testing with technical difficulties, time taken for the results and financial 
implications, also associated are social reasons. This makes genetic counselling for 
hearing impairment very complex. The other difficulties associated with genetic tests is 
the underlying etiological heterogeneity seen in mutations associated with hearing 
impairment. The other problem associated with genetic testing is the limited ways of 
interpreting the test results, as only positive results are easy to interpret, inconclusive 
results due to a variant of mutation or a genetic variant of uncertain significance is 
difficult to interpret in terms of result.These results increase the complexity in terms of 
understanding inheritance of deafness, genetic information, and chances of recurrence in 
future generations. It is difficult to explain to the parents when theaetiology for their 
child‘s deafness remains unknown. In the case of GJB2/GJB6 testing, a positive result 
reveals that a child‘s deafness is genetic in origin, whereas, negative or inconclusive 
results do not provide definitive information about why a child is deaf. Importantly, 
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negative or inconclusive GJB2/GJB6 results do not rule out a genetic form of deafness 
because there are many untested genes that can cause deafness. Although the number of 
studies evaluating knowledge and understanding of genetic information is small, the most 
common finding is misinterpretation of the meaning of a lack of explanation for why a 
child is deaf, either as an outcome of evaluation of clinical and family history information 
or as a result of a negative genetic test result, where individuals tend to equate a negative 
result with ‗not genetic‘ and a zero percent recurrence chance. 
Parents can understand concepts of heterogeneity and inheritance in abstract terms after 
genetic counselling. Studies have shown that the way test results are interpreted by 
parents varies according to the result of the genetic test, whether positive, negative or 
inconclusive. Most of the parents were able to understand when the test results are 
positive. Studies have shown that parents are able to interpret that their child has 
connexion related deafness, it is inherited, and there is a 25% chance of recurrence in 
further pregnancies. All this information can be conveyed to parents by genetic 
counselling.Studies have shown that when parents received inconclusive test results, they 
could understand that the child may still have an inherited deafness and that the aetiology 
of their child‘s deafness was undetermined. These parents have less understanding as 
regards tochances of recurrence. This difficulty in understanding and interpreting of 
results by the parents can be overcome by pre-test and post-test genetic counselling given 
to the parents. More studies are needed to be done to identify the ways of genetic 
counselling and the amount of information to be given to the parents. 
Various studies have demonstrated the diversity of  the attitudes and beliefs of hearing 
parents, deaf parents, and deaf adults regarding genetic testing for deafness, the social 
complexities associated and the difficulties in dealing with these.Genetic tests are useful 
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in various ways, they help in finding out the cause of hearing impairment of the child, 
knowing any chance of recurrence in future pregnancies, and desciding on future family 
planning. Although there are different reasons to do the genetic tests, studies have shown 
that factors like cultural, religious and ethnic heritage determine the acceptability and 
other use of this genetic information.One common concern expressed by most is that this 
genetic information will be used to decide on future reproductive decisions. Another 
concern is that prenatal diagnosis and termination of foetuses with genotypes associated 
with hearing impairment may be practised. 
The hearing screening process for the newborn starts at bedside with audiometric 
screening of all newborns before they are discharged. Any newborn who fails the 
screening test, further diagnostic audiologic evaluation is done in outpatient department. 
During this process of screening parents of the child are in contact with a number of 
different health care professionals including obstetricians, paediatricians, hearing 
screeners, audiologists, otolaryngologists, and early intervention teachers. At present 
there is no guidelines or formal protocol on who among these health care professional 
gives genetic counselling and advices parents regarding the genetic tests. Among the 
health care professional paediatricians and audiologists are in repeated contact with the 
parents,they should be the one to inform parents regarding the need and availability of 
genetic testing. Many studies have shown that most parents feel that genetic testing and 
evaluation if needed should be initiated early. 
Many studies have shown that parents do not believe that genetic testing of their hearing 
impaired children is harmful. Studies have shown that most parents who receive positive 
results in genetic testing feel benefited by the study. They feel that they can understand 
the cause of their child‘s hearing impairment better. This helps them in deciding upon 
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future treatment options and also with future family planning. Parents who receive 
inconclusive or negative results feel less benefit from genetic tests but they do feel some 
benefits in terms of future family planning. In contrast, parents who feel genetic test are 
harmful and will lead to stigma, their views are unlikely to change when they learn their 
child‘s test result. It is important to do pre- and post-test genetic counselling as it can 
improve understanding of parents of negative test results.(47) 
Clinical Utility of Genetic Testing for Hearing Loss  
There are several advantages of genetic tests when compared to conventional hearing loss 
evaluation without genetic testing. (48,49,50) The benefits anticipated from genetic 
testing include:  
1. Reduction of additional time consuming, invasive, and expensive testing;  
2. Choice of early interventions such as hearing aids, cochlear implants, or sign 
language that significantly improve language ability and quality of life outcomes;  
3. Information on the progression of the condition;  
4. Ability to monitor associated clinical manifestations and complications, 
particularly for certain syndromic forms of hearing loss;  
5. Information on the chance of recurrence in the family that can inform reproductive 
decisions; and 
6. Information pertinent to risks and health care decisions (e.g., avoiding 
aminoglycoside antibiotics among those with MTRNR1 mutations). (51) 
It was found in many studies that when compared to traditional evaluation genetic testing 
is more sensitive and specific. A study done at Cincinnati Children‘s Hospital on children 
with hearing impairment found that after the regular evaluation, 80% of hearing impaired 
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chidren remained undiagnosed.(52) Studies have shown that the age at which the hearing 
loss was identified ranged from 12–60 months among children with hearing impairment. 
This delay in diagnosing hearing loss affects language learning and reduces further 
management options. A study about cochlear implants reports, ―There seems to be a 
substantial benefit for both speech and vocabulary outcomes when children receive their 
implant before the age of 2.5 years‖(21) 
GENE THERAPY 
Studies were done for gene therapy by targeted deletion of Cx26 in the inner ear of a 
mouse. The mouse had a GJB2 mutation, 35delG, produced by targeted deletion of a 
single base. This mutation led topremature termination of the Cx26 protein by causing a 
frame shift at  the 12th amino acid. Cx26 gene was delivered using  bovine adeno-
associated viral (BAAV) vectors. Bovine adeno-associated viral (BAAV) vectors are 
efficient in gene transfer and have minimal toxicity.Cochlear non–sensory cells were 
maintained in organotypiccultures.andCx26 gene was delivered using  bovine adeno-
associated viral (BAAV) vectors to restore gap junction coupling. This study showed that 
transduction of cochlear organotypic cultures of inner ear of mouse with targeted deletion 
with  bovine adeno-associated viral (BAAV) vectors at P5 restored Cx26  to the plasma 
membrane of cochlear nonsensory cells. It was also shown that these new molecules of 
connexin 26 also induced formation of functional intercellular channels by docking with 
other molecules at points of contact between adjacent cells of cochlea.(53). 
Gene therapy is a veru useful way of modulating gene expression in the inner ear. Gene 
therapy can help in treating cochlear disorders. Recombinant bovine adeno-associated 
viral (BAAV) vectors have several advantages which make them very useful as means of 
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gene transfer in the inner ear. Recombinant bovine adeno-associated viral (BAAV) 
vectors havedemonstrated efficient gene transfer both in vivo and in vitro. BAAV have a 
unique serological identity and have low toxicity. Bovine associated adeno virus (BAAV) 
show tropism for the inner ear cells. They are also well tolerated by the cochlea [54,55]. 
Studies have reportedtransduction of most of the non-sensory cells by BAAV and they 
are well tolerated. Studies have also shown that in vivo gene therapy it is possible to have 
apical transduction of cochleain utero which would be preferred [48]. Studies have shown 
that sialic acid containing gangliosides are important for BAAV entry and 
transduction.Mammalian cochlea expresses multiple gangliosideson its cell surface[50]. 
Bovine adeno-associated virus (BAAV) exhibits lead tosporadic transduction of sensory 
inner and outer hair cells with increased tropism for cochlear non– sensory cells [48,49]. 
These results in this study showed that suggest that normal connexin levels by gene 
delivery via recombinant AAV can be restored. Thus gene therapy can be used to restore 
hearing function in DFNB1 mouse models. This in future can lead to application in 
therapeutic interventions designed for humans, mainly for children with congenital 
nonsyndromic hearing impairment. (56) 
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PATIENTS AND METHODS 
This is a pilot study conducted in Department of ENT and Medical Genetics, at CMC, 
VELLORE. 96 children were included in the study – 86 being retrospective.  
Children presenting with history of nonsyndromicsensorineural hearing impairment in the 
department of ENT of our hospital were enrolled in the study. . History was obtained 
based on information obtained by a combination of self-reporting and physician 
assessment. Clinical evaluation including physical examination, hearing evaluation, blood 
investigations including genetic test were done. Genetic test were done in Department of 
Clinical Genetics at CMC. 
Methodology of genetic test :  Extracted DNA was amplified using specific primers for 
GJB2 gene by PCR. This was checked in agarose gel & the product were digested using 
restriction enzyme Alu1 to look for W24X mutation. Those negative for above mutation, 
in them PCR was repeated followed by sequencing 
The test were done in the following steps 
1. DNA EXTRACTION – MINI (QIAGIN KIT METHOD) 
AIM:  To isolate DNA from the blood sample using QIAGINI KIT method 
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MATERIALS REQUIRED: 
1. Blood sample 
2. Water bath 
3. Eppendorf tube 
4. Vortex 
5. Absolute alcohol 
6. Centrifuge 
7. Qiagini kit 
PROCEDURE: 
1. Samples must be at room temperature 
2. Water bath set at 560 C 
3. Label the eppendorf tube with patient‘s name and number 
4. Add 20 µl protease K to eppendorf 
5. Add 200 µl EDTA blood to eppendorf 
6. Add 200 µl of AL buffer. Do not shake 
7. Vortex spin 30 seconds X 3 times 
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8. Ordinary spin 30 seconds 
9. Water bath set at 560 C for 5 minutes 
10. Vortex spin 30 seconds X 3 times 
11. Ordinary spin 30 seconds 
12. Water bath set at 560 C for 5 minutes 
13. Vortex spin 30 seconds X 3 times 
14. Ordinary spin 30 seconds 
15. Add 200 µl of absolute alcohol 
16. Vortex spin 30 seconds X 3 times 
17. Ordinary spin 30 seconds 
18. Label columns and pour mixture 
19. Centrifuge at 14000rpm for 3 minutes 
20. Discard the well containing the filtrate, remove upper column and fix in new wells 
21. Add 500 µl of AW1 buffer 
22. Centrifuge at 14000rpm for 3 minutes 
23. Discard the well containing the filtrate, remove upper column and fix in new wells 
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24. Add 500 µl of AW2 buffer 
25. Centrifuge at 14000rpm for 4 minutes 
26. Discard the filtrate and place the spin column in the 1.5ml eppendorf   tube and 
add 200 µl of AE buffer. 
27. Incubate at room temperature for 20 minutes 
28. Centrifuge at 14000rpm for 2 minutes 
29. Incubate at room temperature for overnight and store the extracted DNA 
2. POLYMERASE CHAIN REACTION 
AIM: To amplify the desired region using PCR 
PRINCIPLE: 
Polymerase chain reaction (PCR) is a primer mediated enzymatic amplification of 
specifically cloned or genomic DNA sequences. PCR process was invented by Kary 
Mullis and it has been automated for routine use in laboratories worldwide. The main 
purpose of the PCR process is to amplify template DNA using thermostable DNA 
polymerase enzyme which catalyzes the buffered reaction in which an excess of an 
oligonucleotide primer pair and four deoxynucleoside triphosphates (dNTPs) are used to 
make millions of copies of the target sequence. 
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There are three major steps in a PCR, which are repeated for 30 or 40 cycles. This is done 
on an automated cycler, which can heat and cool the tubes with the reaction mixture in a 
very short time. 
Denaturation at 94°C: 
During the denaturation, the double strand melts open to single stranded DNA, all 
enzymatic reactions stop. 
Annealing at 54°C: 
The primers are jiggling around, caused by the Brownian motion. Ionic bonds are 
constantly formed and broken between the single stranded primer and the single stranded 
template. The more stable bonds last a little bit longer (primers that fit exactly) and on 
that little piece of double stranded DNA (template and primer), the polymerase can attach 
and starts copying the template. Once there are a few bases built in, the ionic bond is so 
strong between the template and the primer, that it does not break anymore. 
Extension at 72°C: 
This is the ideal working temperature for the polymerase. The primers, where there are a 
few bases built in, already have a stronger ionic attraction to the template than the forces 
breaking these attractions. Primers that are on positions with no exact match get loose 
again (because of the higher temperature) and do not give an extension of the fragment.  
The bases (complementary to the template) are coupled to the primer on the 3' side (the 
polymerase adds dNTP's from 5' to 3', reading the template from 3' to 5' side, bases are 
added complementary to the template) 
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3. Because both strands are copied during PCR, there is an exponential increase of the 
number of copies of the gene. The total number of DNA copies after n number of cycles 
is 2
n
. 
Amplification of the GJB2 gene by PCR 
 
COMPONENTS: 
1. Taq DNA polymerase 
The DNA polymerase, known as 'Taq polymerase', is named after the hot-spring 
bacterium Thermusaquaticus from which it was originally isolated. The enzyme can 
withstand the high temperatures needed for DNA-strand separation, and can be left in the 
reaction tube. The cycle of heating and cooling is repeated over and over, stimulating the 
primers to bind to the original sequences and to newly synthesised sequences. The 
enzyme will again extend primer sequences. This cycling of temperatures results in 
copying and then copying of copies, and so on, leading to an exponential increase in the 
number of copies of specific sequences.  Because the amount of DNA placed in the tube 
at the beginning is very small, almost all the DNA at the end of the reaction cycles is 
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copied sequences. Higher Taq DNA polymerase concentrations than needed may cause 
synthesis of non-specific products. 
2. Template DNA 
Nearly any standard method is suitable for template DNA purification. An adequate 
amount of template DNA is between 0.1 and 1 µg for genomic DNA for a total reaction 
mixture of 100 µl. Larger template DNA amounts usually increase the yield of non-
specific PCR products. 
3. Primers (forward and reverse) 
1. PCR primers should be 10-24 nucleotides in length. 
2. The GC content should be 40%-60%. 
3. The primer should not be self-complementary or complementary to any other          
primer in the reaction mixture, to prevent primer-dimer and hairpin formation. 
4. Melting temperatures of primer pairs should not differ by more than 5°C, so that 
the GC content and length must be chosen accordingly.  
5. The melting and annealing temperatures of a primer are estimated as follows: if 
the primer is shorter than 25 nucleotides, the approximate melting temperature is 
calculated with the formula: Tm = 4 (G + C) + 2 (A + T).  
6. The annealing temperature should be about 5°C lower than the melting 
temperature. 
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4. MgCl2 Concentration 
Because Mg2+ ions form complexes with dNTPs, primers and DNA templates, the 
optimal concentration of MgCl2 has to be selected for each experiment. Too few Mg2+ 
ions result in a low yield of PCR product, and too many will increase the yield of non-
specific products. The recommended range of MgCl2 concentration is 1 to 3 mM, under 
the standard reaction conditions specified. 
5. dNTP’s 
The concentration of each dNTP (dATP, dCTP, dGTP, dTTP) in the reaction mixture is 
usually 200 µM. These concentrations must be checked as being equal, because 
inaccuracies will increase the degree of misincorporation. 
MATERIALS REQUIRED: 
1. DNA sample 
2. Master mix  
3. Forward Primer 
4. Reverse Primer 
5. Double distilled water 
6. Thermo cycler (PCR machine) 
7. PCR tubes (0.2ml) 
8. Micro pipettes 
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PROCEDURE: 
1. Label the PCR tubes  
2. Add the following to each of the PCR tubes 
Components Tube 
PCR master mix 11.5 µl 
Primer (F) 1 µl 
Primer (R) 1 µl 
Water 9.5 µl 
DNA sample 1.5 µl 
Total 24.5 µl 
3. Spin the PCR tube with components added using low speed small micro centrifuge 
machine 
4. Place the tubes in the Thermo cycler and set the programme as follows, 
Temperature Time Condition Cycles 
95
0
 C 2 min Denaturation  1 
94
0
 C 30 sec Denaturation 35 
58
0
 C 30 sec Annealing 35 
72
0
 C 30 sec Extension 35 
72
0
 C 10 min Final extension 1 
5. Run the programme. 
6. PCR Product checked on 2 % agarose gel. 
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Gel picture showing the products after digestion with 
Restriction enzyme AluI 10th patient is having W24X 
mutation
1       2       3       4   5      6       7      8      9     10    11    UD   MM
 
4. RESTRICTON DIGESTION 
AIM:  To digest the DNA using Apa 1 
PRINCIPLE: 
Restriction endonucleases are enzymes which recognize and cleave double stranded DNA 
at specific sequences, and are named for the cellular strain from which they are isolated. 
The natural function of the enzymes is to destroy foreign DNA, while the cell‘s own 
DNA is protected from cleavage because it has been specifically modified by cellular 
methylases. Typically, the recognition sites consist of 4-6 (or more) bases arranged in a 
palindromic sequence. Type II restriction enzymes are mostly used in cloning than the 
other types. 
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Alu1: 
Digest the PCR product with Alu1 enzyme. 
PROCEDURE: 
1. Label the tubes 
2. Add the following to 10μl  PCR product 
Buffer  2μl 
Alu I enzyme 1μl 
Sterile water 7μl 
Total  10μl 
3. Mix well 
4. Keep in water bath for 12 hours. 
5. Check the products on 1.5% Agarose gel. To interpret W24X mutation.  
Sequencing done in ABIPrism 3100 sequencer showing heterozygote and 
homozygote 
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Diagram showing the W24X mutation from internet 
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Inclusion criteria: Children less than 16 years old presenting with history of non-
syndromicsensorineural hearing impairment in the department of ENT of our hospital 
were enrolled in the study. Hearing level criteria included permanent childhood hearing 
impairment of 40dB or more in better hearing ear averaged across 500Hz to 4KHz. 
Exclusion criteria:  Children with non-genetic causes of hearing loss (maternal 
infections, prematurity, low birth weight, birth injuries, ototoxins usage, Rh factor 
complications, maternal diabetes, toxaemia during pregnancy &anoxia) were excluded 
from the study. 
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RESULT 
TABLE 1 : Distribution of hearing loss 
HEARING LOSS FREQUENCY PERCENTAGE 
MODERATE 21 21.9% 
MODERATELY SEVERE 5 5.2% 
SEVERE 24 25% 
PROFOUND 46 47.9% 
TOTAL 96 100% 
Among the probands with nonsyndromicsensorineural hearing loss nearly 22% had 
moderate, 5% moderately severe, 25% severe and  48% had profound hearing loss. 
Distribution of hearing loss among the probands 
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TABLE 2 : Gender distribution of the probands 
GENDER DISTRIBUTION FREQUENCY PERCENTAGE 
MALE 36 37.5 
FEMALE 60 62.5 
TOTAL 96 100 
37.5 % of probands were males and 62.5% females 
 
Gender distribution in the probands  
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TABLE 3 : Gender distribution across hearing loss 
GENDER 
DISTRIBUTION 
OF HEARING 
LOSS 
MODERATE 
MODERATELY 
SEVERE 
SEVERE PROFOUND TOTAL 
MALE  8 0 10 18 36 
PERCENTAGE 
WITHIN 
GENDER 
22.2% 0% 27.8% 50% 37.5% 
FEMALE 13 5 14 28 60 
PERCENTAGE 
WITHIN 
GENDER 
21.7% 8.3% 23.3% 46.7% 62.5% 
TOTAL 21 5 21 46 96 
TOTAL 
PERCENTAGE 
21.9% 5.2% 25% 47.9%  
47.9% of probands had profound hearing loss, 50% of males and 46.7% of females 
probands had profound hearing loss   
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TABLE 4 : Distribution across the type of marriage 
MARRIAGE FREQUENCY PERCENTAGE 
CONSANGUINOUS 37 38.5 
NONCONSANGUINOUS 59 61.5 
TOTAL 96 100 
Among the probands studied 38.5 % were born to consanguinous marriage and 61.5% 
born to nonconsanguinous marriage 
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TABLE 5 : Degree of hearing loss in probands born to consanguineous marriages 
HEARING LOSS IN 
CONSANGUINOUS 
MARRIAGE 
MODERATE 
MODERATELY 
SEVERE 
SEVERE PROFOUND TOTAL PERCENTAGE 
CONSANGUINOUS 5 2 7 23 37 38.5 
PERCENTAGE IN  
CONSANGUINOUS 
MARRIAGE 
13.5% 5.4% 18.9% 62.2%   
NONCONSANGUINOUS 16 3 17 23 59 61.5 
PERCENTAGE IN 
ONCONSANGUINOUS 
MARRIAGE 
27.1% 5.1% 28.8% 39%   
TOTAL 21 5 24 46 96  
Among probands born to consanguineous marriage, 62.2% had profound hearing loss as compared to 39% born to nonconsanguinous marriage, 
18.9% had severe hearing loss compared to 28.8%, 5.4% had moderately severe hearing loss compared to 5.1% and 13.5% had moderate hearing 
loss compared to 27.1% 
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 TABLE 6 : Percentage of GJB2 mutation positive in probands 
GJB2 MUTATION FREQUENCY PERCENTAGE 
POSITIVE 13 13.5 
NEGATIVE 83 86.5 
TOTAL 96 100 
13.5% of probands were positive for GJB2 mutation and 86.5% were negative 
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TABLE 7: Gender distribution of GJB2 mutation 
GENDER 
DISTRIBUTION 
OF GJB2 
FREQUENCY TOTAL PERCENTAGE 
MALE 7 36 19.4% 
FEMALE 6 60 10% 
TOTAL 13 96 13.5% 
There are 36 boys and 60 girls in the study. Out of the 36 boys, 19.4% had gjb2 mutation 
and 10% of the girls had that mutation however, this difference was not statistically 
significant. In simple words, there is no evidence of association 
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TABLE 8 : Degree of hearing loss across probands with GJB2 mutation 
HEARING 
LOSS 
ASSOCIATED 
WITH GJB2 
MODERATE MODERATEL
Y SEVERE 
SEVERE PROFOUND TOTAL 
POSITIVE 0 0 0 13 13 
NEGATIVE 21 5 24 33 83 
TOTAL 21 5 24 46 96 
PERCENTAGE 0% 0% 0% 28.3% 13.5% 
All probands with GJB2 mutation had profound hearing loss. 28.3% of profound hearing 
loss probands were positive for GJB2 mutation 
DEGREE OF HEARING LOSS ACROSS PROBANDS WITH HEARING LOSS 
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TABLE 9 : Percentage of w24x positive among GJB2 positive 
W24 X AMONG GJB2 
POSITIVE 
FREQUENCY PERCENTAGE 
POSITIVE 6 47% 
NEGATIVE 7 53% 
TOTAL 13 100% 
47% of GJB2 positive probands tested positive for W24X and 53% tested negative  
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TABLE 10 : Percentage of w24x positive among probands 
W24X AMONG NSSNHL FREQUENCY PERCENTAGE 
POSITIVE 6 6.3% 
NEGATIVE 90 93.8% 
TOTAL 96 100% 
6.3% of probands tested positive for W24X mutation and 93.8% tested negative 
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TABLE 11 : Gender distribution of W24X  
GENDER 
DISTRIBUTION OF 
W24X 
FREQUENCY TOTAL PERCENTAGE 
MALE 2 36 5.6% 
FEMALE 4 60 6.7% 
TOTAL 6 96 6.3% 
 
5.6% of males and 6.7% of females tested positive for W24X, 6.3% of total probands 
tested positive for W24X mutation 
 
 
5.6
6.7
5
5.2
5.4
5.6
5.8
6
6.2
6.4
6.6
6.8
Male Female
p
e
rc
e
n
ta
ge
Sex
Gender  distribution of 
w24x mutation
Male
Female
70 
 
TABLE 12 : Hearing loss across W24X positive probands 
HEARING 
LOSS 
ASSOCIATED 
WITH W24X 
MODERATE 
MODERATELY 
SEVERE 
SEVERE PROFOUND TOTAL 
POSITIVE 0 0 0 6 6 
NEGATIVE 21 5 24 40 90 
TOTAL 21 5 24 46 96 
PERCENTAGE 0% 0% 0% 13% 6.3% 
All probands with W24X had profound hearing loss, 13% of probands with profound 
hearing loss had W24X mutation. 
HEARING LOSS ACROSS W24X POSITIVE PROBANDS 
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TABLE 13 : Association of consanguinity with GJB2 mutation 
MARRIAGE POSITIVE NEGATIVE TOTAL 
CONSANGUINOUS 11 26 37 
PERCENTAGE OF GJB2 
IN CONSANGUINOUS 
29.7% 70.3%  
NONCONSANGUINOUS 2 57 59 
PERCENTAGE OF GJB2 
IN 
NONCONSANGUINOUS 
13.5% 86.5%  
TOTAL 13 83 96 
There are 37 of the children from  consanguineous marriage of which 29.7% had GJB2 
mutation and 3.4% out of non-consanguineous had mutation and this difference was 
highly significant. 
ASSOCIATION OF CONSANGUINITY WITH GJB2 MUTATION 
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DISCUSSION 
This pilot study was done in a tertiary training care centre in India to look at the genetic 
profile of children with nonsyndromicsensorineural hearing loss who had attended our 
OPD.  
In this study there were 96 probands, 36 males and 60 females. Among the probands 46 
i.e. 47.9% had profound hearing loss. 
These children came from different geographic areas of India, and from different cultural 
background. Most of these children came from Tamil Nadu, Andhra Pradesh, West 
Bengal, Bihar and the North eastern states. They came from different cultural background 
with some favoring consanguinity in the population. This study we did not look at any 
pockets or clusters of deaf population, or any deaf schools. So the results in this study are 
different from other studies where they have concentrated on families and populations 
with hearing impairment and also looked at populations where consanguinity is 
commonly practised. 
Deafness associated with mutation at DFNB1 locus on chromosome13q11 is the most 
prevalent type of nonsyndromicsensorineural hearing loss in most parts of the world. 
Connexin 26 (Cx26, genesymbolGJB2) and connexin30 (Cx30, GJB6) are the two genes 
localised to this chromosomal region and both have been implicated in causing the 
hearing loss (43). Connexin 26 (GJB2) and connexin 30 (GJB6) have been reported to be 
the most common cause of  nonsyndromicsensorineural hearing loss, accounting for 30% 
to 40% in different populations (46). Studies in different populations have shown 
different alleles as being more common.Studies done on Ashkenazi Jewish population 
have shown the 167delT mutation to be more common in theirpopulation (39). Another 
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study done on populations in Caucasians and in Mediterranean regions showed 35delG as 
more common.(40). In studies done on Japanese population, 235delC mutations are seen 
commonly.(41)In studies done in Ghana, R143W was found to be more common 
occurring GJB2 variant (42).Studies done in the Kerala population on probands with 
hearing impairment using molecular screening showed that 36% were associated with 
mutations in the connexin26 gene. (46). Similar values were reported in other studies 
done elsewhere in the world . 
In our study we found Connexin 26 mutation in 13.5% of children with 
nonsyndromicsensorineural hearing loss. There are 36 boys and 60 girls in the study. Out 
of the 36 boys, 19.4% had gjb2 mutation and 10% of the girls had that mutation however. 
In simple words, there is no evidence of association. We also found in our study all 
probands with GJB2 mutation had profound hearing loss. 
The most common GJB2 mutation found in the other studies done in India in was W24X 
(46). Interestingly, 35delG, which is one of the most common reported mutations in GJB2 
gene in studies done abroad was not detected in most studies done on Indian population. . 
In another study done recently in a North Indian population, 35delG mutations were 
found along with W24X mutation (45).These studies have shown that different mutations 
are seen in different populations. It also implies that certain mutations are specific for 
same population.(46).  
In our study we found 47% of GJB2 positive probands tested positive for W24X. 6.3% of 
the total probands tested positive for W24X mutation. Out of the total probands 
tested,5.6% of males and 6.7% of females tested positive for W24X. We also found that 
all probands with W24X had profound hearing loss. 
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Studies have shown that high carrier rates of ressive genes is seen in populations with 
high rates of consanguinity.Previous studies have shown a very high rate of consanguinity 
and inbreeding coefficient of South Indian population (56). In our study among the 
probandstested 38.5 % were born to consanguinous marriage. There are 37 of the children 
from  consanguineous marriage of which 29.7% had GJB2 mutation and 3.4% out of non-
consanguineous had mutation and this difference was highly significant Among probands 
born to consanguineous marriage, 62.2% had profound hearing loss as compared to 39% 
born to nonconsanguinous marriage 
The most important benefit of identifying the molecular genetics behind deafness lies in 
the further management. In our study among the probands with 
nonsyndromicsensorineural hearing loss 47.9% had profound hearing loss 
It has been reported that cochlear implant done in patients with GJB2 mutation related 
deafness have better speech performance. Identifying the molecular genetics of hearing 
impairment has benefited the most in deciding on further treatment. Studies have reported 
that cochlear implant patients with GJB2 related deafness have good speech performance 
(57). Hence, identifying GJB2  mutations in hearing impaired children will help in 
providing early intervention and better counselling  
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LIMITATIONS 
Genetic test have high cost and the results take long time. This study needs to be done in 
larger number of children with non-syndromicsensorineural hearing loss. Specific 
populations with deafness and consanguinity need to be addressed. 
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CONCLUSION 
This study has shown that Connexin 26 mutationis less common in India than in western 
population.In our study nearly half of probands with GJB2 mutation were W24X positive 
and this is the commonest mutation in Indians. Nearly one third of consanguineous 
marriage with non-syndromicsensorineural hearing loss were GJB2 positive. In this study 
we also found that all children who were GJB2 positive had profound hearing loss. To 
conclude, genetic test have many benefits and most impotantly if found positive it helps 
in early intervention. 
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APPENDICES 
  
Background  
The objective of DNA bank is to store human DNA to preserve for future analysis for the 
purpose of research and the diagnosis of the genetic diseases.The potential beneficiaries 
are persons seeking counseling at the later date.  
DNA banking is needed for the future requirement of the individuals with a genetic 
disorder and those requiring DNA analysis for confirmation of the diagnosis at the 
molecular level, and also in case of presymtomatic diagnosis, carrier state detection, 
prenatal diagnosis, and resource for research into the molecular pathology of genetic 
disorder. 
DNA banking is indicated  for condition where gene is mapped but molecular analysis not 
readily available and for those where the gene is not mapped. 
There is need for formal written consent prior to blood samples for DNA analysis or 
banking, and hence those willing for are sampled. 
Methodology 
Transport of blood sample 
Blood at ambient temperature for a few days during transport gives adequate DNA yields 
.Blood sample should not be freezed prior to transporting it, because freezing and thawing 
will bring down the integrity and yield of DNA by way of its degradation. 
Type of samples 
Venous blood 
Venous blood in EDTA tube is the choice and convenient sample from the pointof view 
of DNA extraction. It is difficult to extract DNA from clotted sample and also the yield 
will be low.About 10 ml(split into two 10 ml aliquots one aliquot for near analysis and 
other aliquot for long term analysis) is adequate for routine use, this provides about 800 
micrograms of DNA.Glass container should be avoided as they are unsuitable for 
freezing.  
Till date these are the guidelines and they are subject to change. 
 
 
CLINICAL GENETICS UNIT, CMC, VELLORE 
   Consensus for DNA banking and consent to be taken for DNA banking 
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Pathological sample(autopsied) 
Liver is a rich source of DNA when it is fresh, but it undergoes rapid autolysis, therefore 
beyond 24 hours spleen is a good choice.  
Storage of wholeblood  and DNA 
Storage of blood 
The water shortens the shelf life of DNA. In wet environment DNA undergoes 
hydrolysis, for long term storage blood should be stored at -80 degree centigrade. 
The whole blood can be stored for good DNA yield  if samples stored at -20 degree 
centigrade for up to two years, storage at -70 degree centigrade is preferred as in event of 
freezer failure it takes longer time to warm up. 
Long term storage  of blood is not advisable because: 
(1) Yield of DNA from whole blood sample is variable,it can be low as zero. 
(2)Blood is transported in different sized container which hinders efficient storage 
(3)Blood is more vulnerable to freezer failure which may cause degradation of DNA. 
(4) Concern that yield may be reduced if blood stored is stored for long time. 
Storage of DNA 
DNA will be stored in a solution in 2 aliquots -70 degree centigrade,Sample required to  
be sent for outside testing be kept at 4degree centigrade for a maximum of two weeks. 
Samples for long term storage be banked at -70degree centigrade for a maximum of 10 
years  
Stability of purified DNA can be preserved upto two years when stored at 4 degree 
centigrade,upto seven years at -18 degree centigrade and longer than seven years when 
stored at -80 degree centigrade. 
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Reporting 
When the sample is received and no DNA analysis is carried out then a document stating 
that  DNA has been successfully extracted and stored will be given to the patient and 
another in . patient‘s record. 
 
Documentation with each specimen-sample should be submitted with a request form.For 
each family ,the DNA bank should have –Pedigree number, family pedigree, 
surname,firstname,date of birth,diagnosis,summary of diagnostic criteria.     
Our contact address:  
Clinical Genetics Unit                      
OT, Block, 5
th
 Floor 
ChristianMedicalCollege& Hospital 
Vellore – 632 004 
Tamil Nadu.India. 
Phone : 0416-3073161  
Fax: 0416-2211196 
Email – medgen@cmcvellore.ac.in 
 
Reference: 
1. Yates John RW et al Journal of Medical genetics 1989 26, 245-250  
2. Recommendations of the European Society of Human Genetics – European Journal of 
Human Genetics (2003) 11, Suppl 2, S8-S10. 
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Consent for DNA banking  
 
1. I have been explained in my own words that the purpose of DNA BANKING is solely for 
research purpose.  
2. I understand that storing blood for DNA extraction does not guarantee that a test will be 
done and the result will be available. 
3. I hereby consent to store my blood and bloods of individuals of my family for DNA 
extraction and carrying out research as and when required. 
4.  I have the right to withdraw from research and I have been explained that DNA banking 
will not hamper ongoing treatment. 
5. I have no objection for discussion and publication of the results in scientific meetings and 
literatures. 
6. I am aware that the DNA will be banked for a maximum of 10 years from the date of 
collection but there is no guarantee on the DNA quality. 
7. A part of this sample not used for diagnostic testing may be stored and used for medical 
research or education with full confidentiality being maintained. In some cases, it may be 
possible for the institute to reanalyze the left over DNA samples in the future using new 
and improved methods. 
 
Proband Name:                                      CMC Hospital No.             DNA No.:    
 
Mobile No.: 
Land line: 
Email id:  
 
             Pedigree:   (if needed) 
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Patient’s Data 
 
          Signature of patient/relatives                                     Doctor‘s name and signature 
DNA consent form version  01.11.12 
FORM/MGEN/002/P/02/072011 
Study on Congenital Nonsyndromicsensorineural Hearing Impairment 
Dept. of ENT & Medical Genetics, CMC, VELLORE 
  
ProbandName  
CMCH No.  
Date of birth  
Date of sample  
ProbandDNA number 
 
Pedigree no. (if applicable) 
Family members: 
Sl.N
o 
Name Relation-
ship 
DNA 
No. 
Date of 
birth 
Signature CMC No. (if 
exists) 
 
 
 
      
 
 
      
 
 
      
 
 
      
 
Name and address of  
the submitting person 
 
 
 
 
 
 
 
 
 
 
Diagnostic criteria 
 
1. 
2. 
3. 
 4. 
5. 
Diagnosis 
 
 
Purpose of investigation 
 
1.Diagnostic 
 
2.Research 
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Appendix 1 
CLINICAL DATA FORM 
Proband code / Diagnosis 
Proband DNA sample taken yes/no 
Family DNA sample taken yes/no 
Birthplace / Birth date 
Paternal history 
Birthplace / birth date 
Noise exposure / mutagens exposure  yes/no 
Deafness / hypoacusis  yes/no 
Audiometry performed / audiological findings 
Other known diseases 
Maternal history 
Birthplace / birth date 
Noise exposure / mutagens exposure  yes/no 
Deafness / hypoacusis  yes/no 
Audiometry performed / audiological findings 
Other known diseases 
Proband gestation 
Duration weeks                           weight gain                           fetal activity 
Infections in pregnancy  yes/no 
TORCH serology available   yes/no 
Alcohol  yes/no 
Drugs in pregnancy  
Other problems in pregnancy 
Proband birth 
Mode                                                birth weight 
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Jaundice                       anoxia                         trauma                         APGAR score 
Other problems at birth 
 
General health 
Previous serious illness 
Meningoencephalitis 
Hospitalization 
Exposure to ototoxic agents  (a) drugs 
                                                    (b) infection 
                                                    (c) noise 
Growth 
Developmental progress 
Normal psychomotor development      yes/no 
Holding head           age   Sitting           age   Standing              age   walking              age 
Speech present    yes/no lallation             age  single words                 age  words in 
sentences      age 
Behaviour  
Age of onset of deafness 
Rate of progression of deafness 
Suspected causative agents 
Pedigree 
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Proband phenotypic evaluation 
 
TFT 
URINE 
ECG 
PTA 
OAE 
ABR 
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MASTER CHART 
Sno Age Sex Hearing Loss Marriage GJB2 Mutation W24x gene 
1 10 yrs 2 4 2 2 2 
2 7 yrs 1 3 2 2 2 
3 4 yrs 2 3 2 2 2 
4 12 yrs 1 4 1 2 2 
5 7 yrs 1 3 2 2 2 
6 12 yrs 1 4 1 2 2 
7 5 yrs 2 2 2 2 2 
8 14 yrs 2 4 2 2 2 
9 7 yrs 1 4 2 2 2 
10 12 yrs 2 3 2 2 2 
11 4 yrs 2 4 2 2 2 
12 8 yrs 1 4 2 2 2 
13 14 yrs 2 3 2 2 2 
14 8 yrs 2 3 2 2 2 
15 13 yrs 2 4 1 2 2 
16 1 year 1 4 2 2 2 
17 6 yrs 2 4 2 2 2 
18 4 months 2 3 1 2 2 
19 2 months 2 2 1 2 2 
20 3 yrs 2 4 1 2 2 
21 1 year 2 4 1 2 2 
22 3 yrs 2 1 2 2 2 
23 4 months 1 3 1 2 2 
24 4 months 2 1 2 2 2 
25 1 year 2 1 2 2 2 
26 3 yrs 1 3 2 2 2 
27 3 yrs 1 1 1 2 2 
28 8 months 2 3 2 2 2 
29 1 year 2 1 1 2 2 
30 1 year 2 1 2 2 2 
31 6 months 1 1 2 2 2 
32 1 year 2 1 1 2 2 
33 2 yrs 2 4 1 1 2 
34 1 year 1 4 1 1 2 
35 2 yrs 2 3 2 2 2 
36 6 months 2 1 2 2 2 
37 2 months 2 3 2 2 2 
38 4 months 1 1 2 2 2 
39 6 months 2 2 2 2 2 
40 3 yrs 1 4 1 1 2 
41 3 months 1 4 2 1 2 
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42 4 months 2 4 1 1 1 
43 9 months 1 1 2 2 2 
44 2 yrs 1 3 1 2 2 
45 3 yrs 1 4 1 2 2 
46 3 yrs 2 3 2 2 2 
47 2 yrs 2 4 1 1 2 
48 2 yrs 1 1 1 2 2 
49 2 yrs 2 2 1 2 2 
50 7 months 1 3 1 2 2 
51 2 yrs 2 1 2 2 2 
52 7 months 2 3 1 2 2 
53 6 months 2 1 1 2 2 
54 5 months 1 4 2 2 2 
55 4 yrs 1 4 1 2 2 
56 9 months 2 3 2 2 2 
57 2 yrs 2 4 1 1 1 
58 3 yrs 1 4 1 1 1 
59 3 yrs 2 1 2 2 2 
60 8 yrs 1 4 2 1 2 
61 1 yr 2 4 2 2 2 
62 2 yrs 2 4 2 2 2 
63 7 yrs 2 4 2 2 2 
64 5, yrs 1 1 2 2 2 
65 5, yrs 1 1 2 2 2 
66 5, yrs 2 2 2 2 2 
67 4 yrs 2 1 2 2 2 
68 12 yrs 2 3 2 2 2 
69 8 yrs 1 3 2 2 2 
70 2 yrs 1 4 1 2 2 
71 1 year 1 1 2 2 2 
72 4 yrs 2 4 1 2 2 
73 2 yrs 2 4 2 2 2 
74 2 yrs 2 4 2 2 2 
75 1 year 2 3 1 2 2 
76 6 yrs 2 4 2 2 2 
77 6 yrs 2 4 2 2 2 
78 5 yrs 1 4 1 1 1 
79 3 yrs 1 3 2 2 2 
80 4 yrs 2 1 2 2 2 
81 5 yrs 2 4 2 2 2 
82 6 yrs 2 4 2 2 2 
83 9 yrs 2 4 1 2 2 
84 7 yrs 2 3 2 2 2 
85 2 yrs 2 1 2 2 2 
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86 4 yrs 1 4 2 2 2 
87 6 yrs 2 4 1 1 1 
88 9 yrs 1 3 2 2 2 
89 8 yrs 2 4 2 2 2 
90 9 yrs 2 4 1 2 2 
91 12 yrs 2 4 1 1 1 
92 9 yrs 1 4 1 1 2 
93 1 year 2 4 1 2 2 
94 4 years 1 4 2 2 2 
95 7 yrs 1 3 1 2 2 
96 1 year 2 4 2 2 2 
 




